PDS Biotechnology (FRA:EU6) Net Change in Cash : €-16.13 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PDS Biotechnology Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

PDS Biotechnology's Net Change in Cash for the three months ended in Dec. 2023 was €2.12 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was €-16.13 Mil.

PDS Biotechnology Net Change in Cash Historical Data

The historical data trend for PDS Biotechnology's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PDS Biotechnology Net Change in Cash Chart

PDS Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

10.85

13.71

32.22

8.10

-15.83

PDS Biotechnology Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															2.06	-8.05	-4.22	-5.97	2.12

PDS Biotechnology Net Change in Cash Calculation

PDS Biotechnology's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-30.844	+	0	+	15.017	+	0
	=	-15.83

PDS Biotechnology's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -7.755 + 0 + 9.872 + 0

= 2.12

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-16.13 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PDS Biotechnology Net Change in Cash Related Terms
Thank you for viewing the detailed overview of PDS Biotechnology's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

PDS Biotechnology (FRA:EU6) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PDS Biotechnology Corp (FRA:EU6) » Definitions » Net Change in Cash

Comparable Companies

ATRA PRAX ABOS VAXX LRMR ALT PEPG MRSN ADAP GALT OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

PDSB:USA

Address

25B Vreeland Road, Suite 300, Florham Park, NJ, USA, 07932

Website

https://www.pdsbiotech.com

PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

PDS Biotechnology (FRA:EU6) Headlines

No Headlines